|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 09-04 | Biosynex: creditors to vote on financial safeguard plan |  |
| 08-06 | Biosynex hit by cyberattack, operational activity remains intact | |
Company Valuation: Biosynex
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 151.6 | 289.9 | 141 | 85.85 | 18.51 | 11.17 |
| Change | - | 91.16% | -51.35% | -39.13% | -78.44% | -39.63% |
| Enterprise Value (EV) 1 | 130.6 | 193.2 | 105.9 | 125.7 | 71.44 | 64.36 |
| Change | - | 47.93% | -45.16% | 18.6% | -43.14% | -9.91% |
| P/E | 5.44x | 2.63x | 9.08x | -2.42x | -0.43x | -0.19x |
| PBR | 2.29x | 1.62x | 0.87x | 0.72x | 0.23x | 0.3x |
| PEG | - | 0x | -0.1x | 0x | -0x | 0x |
| Capitalization / Revenue | 0.99x | 0.76x | 0.72x | 0.92x | 0.18x | 0.12x |
| EV / Revenue | 0.85x | 0.5x | 0.54x | 1.35x | 0.71x | 0.68x |
| EV / EBITDA | 2.84x | 1.36x | 2.28x | -4.21x | -3.22x | -4.72x |
| EV / EBIT | 2.86x | 1.37x | 2.72x | -3.48x | -2.59x | -2.47x |
| EV / FCF | 7.61x | 2.62x | -3.59x | -2.83x | -43.6x | 4.54x |
| FCF Yield | 13.1% | 38.1% | -27.9% | -35.3% | -2.29% | 22% |
| Dividend per Share 2 | 0.2 | 2 | - | - | - | - |
| Rate of return | 1.2% | 7.6% | - | - | - | - |
| EPS 2 | 3.05 | 10.01 | 1.52 | -3.45 | -4.03 | -3.159 |
| Distribution rate | 6.56% | 20% | - | - | - | - |
| Net sales 1 | 153.9 | 382.5 | 196.6 | 92.98 | 101.2 | 95.19 |
| EBITDA 1 | 46.02 | 141.8 | 46.49 | -29.82 | -22.16 | -13.64 |
| EBIT 1 | 45.73 | 140.7 | 38.88 | -36.15 | -27.53 | -26.05 |
| Net income 1 | 31.37 | 104 | 15.66 | -36.95 | -43.33 | -58.22 |
| Net Debt 1 | -21.07 | -96.72 | -35.09 | 39.8 | 52.94 | 53.19 |
| Reference price 2 | 16.6000 | 26.3200 | 13.8000 | 8.3500 | 1.7200 | 0.5960 |
| Nbr of stocks (in thousands) | 9,135 | 11,014 | 10,220 | 10,281 | 10,761 | 18,748 |
| Announcement Date | 21/04/21 | 25/04/22 | 28/04/23 | 30/04/24 | 30/04/25 | 07/05/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -48.83x | 16.02x | -116.95x | -.--% | 21.12B | |
| 17.24x | 1.91x | 8.08x | 1.48% | 9.62B | |
| -95.51x | 13.66x | -129.79x | -.--% | 8.94B | |
| 184.63x | 6.28x | 36.1x | -.--% | 6.88B | |
| 21.25x | 4.22x | 11.65x | - | 6.54B | |
| 20.4x | 7.05x | 15.84x | 2.82% | 5.64B | |
| 21.24x | 3.52x | 10.89x | 1.77% | 4.22B | |
| 16.45x | - | - | 3.73% | 2.65B | |
| Average | 17.11x | 7.52x | -23.45x | 1.4% | 8.2B | |
| Weighted average by Cap. | -0.94x | 9.60x | -49.12x | 0.81% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALBIO Stock
- BSYXF Stock
- Valuation Biosynex
Select your edition
All financial news and data tailored to specific country editions
